SCHEMBL5679972

SCHEMBL5679972

NS(=O)(=O)c1ccc(C=O)cc1Cc1cccs1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CISD1 Q9NZ45 1/20 0.37
▸ L3MBTL1 Q9Y468 3/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ CYP2C9 P11712 1/20 0.36
▸ CA1 P00915 8/20 0.35
▸ CA2 P00918 8/20 0.35
▸ CA5A P35218 7/20 0.35
▸ CA7 P43166 7/20 0.35
▸ CA5B Q9Y2D0 7/20 0.35
▸ CA12 O43570 3/20 0.35
▸ CA9 Q16790 3/20 0.35
▸ CA13 Q8N1Q1 2/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ CACNA1B Q00975 1/20 0.34
▸ APBA1 Q02410 1/20 0.34
▸ CTDSP1 Q9GZU7 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3559017 0.79 MAOA (0.42) CA1CA2CA5ACA12CA9
SCHEMBL1874184 0.78 CYP2C9 (0.42) CISD1L3MBTL1KDM4ECYP2C9CA1
SCHEMBL5679966 0.71 CA2 (0.39) CYP2C9CA1CA2CA5ACA7
SCHEMBL19387618 0.71 CA2 (0.36) KDM4ECA1CA2CA12CA9
SCHEMBL10869347 0.70 CA1 (0.43) CISD1L3MBTL1KDM4ECYP2C9CA1
SCHEMBL9414144 0.68 CYP2C9 (0.44) KDM4ECYP2C9KMT2APOLBALDH1A1
SCHEMBL28225354 0.67 L3MBTL1 (0.61) L3MBTL1KDM4ECA1CA2CA5A
SCHEMBL15274410 0.65 CYP2C9 (0.44) KDM4ECYP2C9MEN1KMT2APOLB
SCHEMBL28862587 0.65 CA1 (0.46) L3MBTL1KDM4ECYP2C9CA1CA2
SCHEMBL23200538 0.65 ALDH1A1 (0.42) KDM4ECA1CA2CA5ACA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613313-A1 2-PHENYL-BENZIMIDAZOL AND 2-PHENYL-IMIDAZO-4,5!-PYRIDINE DERIVATIVES AS CHECKPOINT KINASE CDS1 (CHK2) INHIBITORS FOR THE TREATMENT OF CANCER JANSSEN PHARMACEUTICA N.V. (BE) 2006-01-11 — — EP disclosed
WO-2004093873-A1 2-PHENYL-BENZIMIDAZOL AND 2-PHENYL-IMIDAZO-`4,5!-PYRIDINE DERIVATIVES AS CHECKPOINT KINASE CDS1 (CHK2) INHIBITORS FOR THE TREATMENT OF CANCER JANSSEN PHARMACEUTICA, N.V. (BE) 2004-11-04 — — WO disclosed
Send feedback